[Evolution of cardiovascular risk factors in patients undergoing percutaneous coronary intervention]

Jael Voces-Álvarez1, Gabriel J Díaz-Grávalos2

  • 1Escuela Universitaria de Enfermería de Ourense, Universidad de Vigo, Ourense, España.

Enfermeria Clinica
|June 9, 2015
PubMed

Insights

Controlling cardiovascular risk factors after percutaneous coronary intervention (PCI) is crucial. While blood pressure and cholesterol improved six months post-PCI, many patients still had uncontrolled risk factors, with age and chronic kidney disease linked to new events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Cardiovascular risk factors (CVRF) significantly impact outcomes following percutaneous coronary intervention (PCI) for ischemic heart disease.
  • Effective management of CVRF is essential for improving patient prognosis after PCI.

Purpose of the Study:

  • To evaluate the changes in CVRF six months after PCI.
  • To determine the association between CVRF and the occurrence of new cardiovascular events post-PCI.

Main Methods:

  • A descriptive case series study analyzed data from 222 patients.
  • Key variables included age, sex, chronic kidney disease (CKD), cholesterol, blood pressure, smoking status, and BMI, measured before and 6 months after PCI.
  • Logistic regression was used to identify predictors of new events (death or repeat PCI).

Main Results:

  • The study included 222 patients (75.2% male, mean age 70.2 years).
  • Prevalence of hypertension, hyperlipidemia, smoking, and diabetes was high (57.7%, 55.9%, 50.4%, 28.2% respectively).
  • Six months post-PCI, blood pressure and total cholesterol decreased, but 33% had uncontrolled CVRF. New events occurred in 5% (death) and 15.3% (new PCI). Age (OR 1.06) and CKD (OR 3.7) were associated with new events.

Conclusions:

  • A high prevalence of CVRF exists in patients undergoing PCI.
  • While some CVRF like blood pressure and cholesterol showed improvement, overall control remained incomplete at six months.
  • New cardiovascular events were observed in a significant proportion of patients, with advanced age and CKD identified as key risk factors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
783
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.8K